This study aimed to evaluate the tolerance and safety of a low-protein formula in healthy full-term infants by investigating effects on growth and gastrointestinal tolerance and by identifying any adverse effects.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Evaluate weight
Timeframe: enrollment, 2 months and 4 months
Evaluate lenght
Timeframe: enrollment 2 months and 4 months
Evaluate head circumference
Timeframe: enrollment 2 months and 4 months
Evaluate body composition (fat mass and fat free mass)
Timeframe: enrollment, 2 months and 4 months
Evaluate weight increase
Timeframe: 2 months, 4 months
Evaluate gastrointestinal tolerance
Timeframe: 2 months and 4 months
Evaluate occurence of adverse events
Timeframe: 2 months and 4 months